Shares of Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $19.50.
A number of research firms have weighed in on ASPN. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Oppenheimer downgraded Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 8th. Finally, Barclays downgraded Aspen Aerogels from an “equal weight” rating to an “underweight” rating and raised their price target for the company from $7.00 to $16.00 in a research report on Monday.
Get Our Latest Analysis on ASPN
Aspen Aerogels Price Performance
Aspen Aerogels (NYSE:ASPN – Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%. The business had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. During the same quarter last year, the business posted $0.21 earnings per share. The company’s revenue for the quarter was down 33.8% on a year-over-year basis. On average, analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. Invesco Ltd. grew its stake in shares of Aspen Aerogels by 3.5% in the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock worth $604,000 after purchasing an additional 1,724 shares during the last quarter. Alps Advisors Inc. grew its stake in shares of Aspen Aerogels by 1.7% in the first quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company’s stock worth $807,000 after purchasing an additional 2,093 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of Aspen Aerogels by 6.3% in the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock worth $425,000 after purchasing an additional 2,118 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Aspen Aerogels by 3.6% in the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after purchasing an additional 2,324 shares during the last quarter. Finally, SBI Securities Co. Ltd. grew its stake in shares of Aspen Aerogels by 67.3% in the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after purchasing an additional 2,551 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Quiet Period Expirations Explained
- NFL and WWE Land on ESPN—The Impact on Disney and TKO Stocks
- What is a Death Cross in Stocks?
- If Qualcomm Holds $145, Its Next Move Could Be Massive
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Intel’s White House Reset: From Political Storm to a Clearer Sky
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.